|Drug Name||GPCR-targeted Project 018|
Frizzled 4 (FZD4) belongs to the frizzled receptors family. It is a receptor for Wnt proteins, which can activate both Wnt/β-catenin canonical and Wnt/Ca2+ non canonical pathways. FZD4 plays an important role in retinal vascularization by binding Norrin ligand, a Wnt-unrelated growth factor, and activating the β-catenin signaling pathway. In addition, dysregulation of FZD4 expression has been reported in different type of cancers.
|Target||Frizzled 4 (FZD4)|
|Drug Modality||Monoclonal antibody|
|Indication||Familial exudative vitreoretinopathy; Cancers|
|Mechanism of Action||Frizzled 4 modulators|
We look forward to hearing from you.
Protheragen's business is growing rapidly after founded in Ronkonkoma, New York. Our business has evolved from the initial intermediary service to encompass segments in equity investment and program incubation.